Trials / Conditions / Advanced Biliary Tract Cancer(BTC)
Advanced Biliary Tract Cancer(BTC)
4 registered clinical trials studyying Advanced Biliary Tract Cancer(BTC) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. NCT07369791 | National Health Research Institutes, Taiwan | Phase 2 |
| Not Yet Recruiting | A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers NCT07351591 | Eastern Hepatobiliary Surgery Hospital | Phase 2 |
| Recruiting | A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Adva NCT07326137 | Tongji Hospital | — |
| Completed | A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract NCT02425137 | TTY Biopharm | Phase 2 |